Physician

Rex B Mowat, MD

According to 2025 Medicare claims, Rex Mowat, MD (NPI: 1346247251) practices hematology/oncology in the Toledo, OH market, with the plurality of this provider's patient population coming from Wood, OH. This provider's primary affiliated billing organization is TOLEDO CLINIC INCORPORATED (NPI: 1144217894; TIN: 340936207) and primary practice location at 43402-2646. Mowat is affiliated with the Mercy Health Select, LLC (ACO ID: A1215) and CVS Accountable Care Organization, Inc. (ACO ID: D0061), participating under both the MSSP and REACH models.

Mowat's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 695 traditional Medicare patients, billed 166,452 HCPCS/CPT codes, and received $2,541,005 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,031 prescription claims across 242 beneficiaries totaling $4,359,002 in drug costs, led by Ibrance (Palbociclib). 2023 DME data shows 30 claims. Open Payments data shows 87 records totaling $143,371. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $1,942,772 to $4,359,002. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $2,183 and ending at $7,402.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.3M$2.6M2015 Medicare payment: $2,560,492 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $2,010,656 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,491,102 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,018,551 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,677,291 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,983,186 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $2,113,892 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,764,862 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,817,199 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,541,005 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015844153,288$2,560,492
2016797115,432$2,010,656
201788763,785$1,491,102
201872643,131$1,018,551
2019853105,589$1,677,291
2020769110,975$1,983,186
2021675111,654$2,113,892
202264589,958$1,764,862
2023632101,854$1,817,199
2024695166,452$2,541,005

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$2.3M$4.6M2015 Drug cost: $1,942,772 (USD; Tot_Drug_Cst)2016 Drug cost: $2,601,263 (USD; Tot_Drug_Cst)2017 Drug cost: $1,802,546 (USD; Tot_Drug_Cst)2018 Drug cost: $3,188,734 (USD; Tot_Drug_Cst)2019 Drug cost: $3,754,693 (USD; Tot_Drug_Cst)2020 Drug cost: $3,732,908 (USD; Tot_Drug_Cst)2021 Drug cost: $3,251,180 (USD; Tot_Drug_Cst)2022 Drug cost: $3,677,585 (USD; Tot_Drug_Cst)2023 Drug cost: $4,559,679 (USD; Tot_Drug_Cst)2024 Drug cost: $4,359,002 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20152851,548$1,942,772
20162851,417$2,601,263
20172751,255$1,802,546
20182571,325$3,188,734
20192711,377$3,754,693
20202641,409$3,732,908
20212551,304$3,251,180
20222341,103$3,677,585
20232221,099$4,559,679
20242421,031$4,359,002

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$20K$40K2015 Medicare payment: $27,610 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $22,567 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $39,635 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $1,979 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $4,700 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $6,425 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $5,308 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $1,388 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $3,140 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R58$27,610
2016N/R86$22,567
201730132$39,635
2018N/R46$1,979
2019N/R54$4,700
2020N/R69$6,425
2021N/R78$5,308
2022N/R33$1,388
2023N/R30$3,140
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more221481$90
96413Administration of chemotherapy into vein, 1 hour or less72304$89
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more373520$62
96365Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less84182$43
96372Injection of drug or substance under skin or into muscle93268$10

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
IbrancePalbociclib631,781$967,006
ImbruvicaIbrutinib451,260$682,678
EmpaveliPegcetacoplan11330$520,572
BrukinsaZanubrutinib23690$250,513
CalquenceAcalabrutinib Maleate15450$227,765

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.41$1,472Cornerstone Specialty Network LLC
Research PaymentsReported research-related payment or transfer-of-value amount.45$141,899ABBVIE INC.
Ownership / Investment InterestsReported value of ownership or investment interests.1$17,400Cornerstone Specialty Network LLC

FAQ

What Medicare data is available for Rex B. Mowat, MD?

Tedicare shows public-source Medicare data for Rex B. Mowat, MD (NPI 1346247251), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Rex B. Mowat, MD have ACO affiliation data?

Rex B. Mowat, MD is shown with ACO affiliation data for Mercy Health Select, LLC (MSSP, ACO ID A1215) and CVS Accountable Care Organization, Inc. (REACH, ACO ID D0061).

What billing organization is linked to Rex B. Mowat, MD?

Rex B. Mowat, MD is linked to TOLEDO CLINIC INCORPORATED (billing NPI 1144217894) in the available physician profile data.

Does Rex B. Mowat, MD have Open Payments data?

Rex B. Mowat, MD has 87 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.